[1] |
de Figueiredo P, Ficht TA, Rice-Ficht A, et al. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions[J]. Am J Pathol,2015,185(6):1505-1517.
|
[2] |
Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis[J]. PLoS Negl Trop Dis,2012,6(12):e1929.
|
[3] |
Franco MP, Mulder M, Gilman RH, et al. Human brucellosis[J]. Lancet Infect Dis,2007,7(12):775-786.
|
[4] |
Al DS, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy[J]. Expert Rev Anti Infect Ther,2011,9(7):833-845.
|
[5] |
Al DS, Sprague LD, Neubauer H. New developments in the diagnostic procedures for zoonotic brucellosis in humans[J]. Rev Sci Tech,2013,32(1):177-88.
|
[6] |
Hasanjani RMR, Marashi SM, Moulana Z. Polymerase chain reaction-based assays for the diagnosis of active and relapsed cases of human brucellosis[J]. Am J Trop Med Hyg,2016,95(6):1272-1276.
|
[7] |
Wang Y, Wang Z, Zhang Y, et al. Polymerase chain reaction-based assays for the diagnosis of human brucellosis[J]. Ann Clin Microbiol Antimicrob,2014,13:31.
|
[8] |
中华人民共和国卫生部. 布鲁氏菌病诊疗指南(试行)[J]. 传染病信息,2012,25(6):323-324.
|
[9] |
Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis[J]. Lancet Infect Dis,2006,6(2):91-99.
|
[10] |
Lai S, Zhou H, Xiong W, et al. Changing epidemiology of human brucellosis, China, 1955-2014[J]. Emerg Infect Dis,2017,23(2):184-194.
|
[11] |
刘熹, 姜海, 田国忠, 等. 对2004-2014年人间布鲁杆菌病实验室检测方法的系统评价[J]. 中华地方病学杂志,2015,34(12):920-925.
|
[12] |
Yohannes M, Gill JP, Ghatak S, et al. Comparative evaluation of the Rose Bengal plate test, standard tube agglutination test and complement fixation test for the diagnosis of human brucellosis[J]. Rev Sci Tech,2012,31(3):979-984.
|
[13] |
王淑云, 刘熹, 荣蓉, 等. 五种布鲁菌血清学检测方法对比分析[J]. 中华预防医学杂志,2016,50(2):175-8.
|
[14] |
Andriopoulos P, Kalogerakou A, Rebelou D, et al. Prevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests[J]. Infection,2015,43(3):325-330.
|
[15] |
Shemesh AA, Yagupsky P. Limitations of the standard agglutination test for detecting patients with Brucella melitensis bacteremia[J]. Vector Borne Zoonotic Dis,2011,11(12):1599-1601.
|
[16] |
Yildiz F, Tanyel E, Hatipoğlu CA, et al. Evaluation of Brucella tube agglutination test in patients with brucellosis, patients with bacterial infections other than brucellosis and healthy subjects[J]. Mikrobiyol Bul,2005,39(2):211-217.
|
[17] |
Buzğan T, Karsen H, Karahocagil MK, et al. A case of brucellosis presenting as high titer negative result by standard tube agglutination test[J]. Mikrobiyol Bul, 2007,41(1):151-4.
|
[18] |
Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis[J]. Clin Infect Dis,2004,39(2):206-217.
|
[19] |
Navarro JM, Mendoza J, Leiva J, et al. C-reactive protein as a prognostic indicator in acute brucellosis[J]. Diagn Microbiol Infect Dis,1990,13(3):269-270.
|
[20] |
Okan DH, Gõkmen Z, Seyit B, et al. Mean platelet volume in brucellosis: correlation between brucella standard serum agglutination test results, platelet count, and C-reactive protein[J]. Afr Health Sci,2014,14(4):797-801.
|
[21] |
Elfaki MG, Al-Hokail AA, Nakeeb SM, et al. Evaluation of culture, tube agglutination, and PCR methods for the diagnosis of brucellosis in humans[J]. Med Sci Monit,2005,11(11):69-74.
|